Clinical and Translational

Advancing Personalized Oncology with Transcriptomic Profiling and Mechanistic Modeling

10 views
June 11, 2021
In this webinar, Moritz Schütte, head of next-generation sequencing data analysis at Alacris, will explore the advantages of RNA sequencing alone or in combination with whole-exome sequencing as part of a precision oncology workflow.

In addition to discussing how RNA-seq identifies molecular alterations and illuminates the tumor microenvironment, Dr. Schütte will explain how mathematical modeling of molecular data can predict drug sensitivity. Applications will be shown for metastatic melanoma and acute lymphoblastic leukemia.

In this webinar, you will learn:

How comprehensive analysis is able to detect actionable targets not accessible by panel analysis;
How deep transcriptome profiling gives insights into the tumor microenvironment and immune composition;
How transcriptome sequencing can be applied for molecular profiling of acute lymphoblastic leukemias in relapse;
How mechanistic modeling offers a highly complementary information layer and enables in silico testing of drug response.

Related videos

Clinical and Translational

QCI Interpret One - Oncology variant interpretation just got more precise

63 views May 10, 2021

Competing to offer a comprehensive genomic profiling service for solid or...

Clinical and Translational

Rapid, evidence-based reporting of oncology NGS tests at scale

37 views May 10, 2021

Competing to offer a comprehensive genomic profiling service for solid or...

Clinical and Translational

Rapid, evidence-based reporting of oncology NGS tests at scale

197 views October 16, 2020

As NGS panels increase in size and complexity, many clinical labs are asking,...

Clinical and Translational

Cancer Gene Variant Detection Using a Pre-Optimized Sample to Report Workflow

233 views October 30, 2019

BRCA1/BRCA2 genes represent the best examples for our current understanding...